Test Price
2,800 AED✅ Home Collection Available
FARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 14 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Executive Summary: 99.9% Diagnostic Sensitivity via ISO 9001:2015-accredited NGS sequencing at our Dubai reference laboratory. Enjoy premium VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM), complimentary pre- and post-test telehealth genetic counselling, and direct billing verification via WhatsApp at +971 54 548 8731. Test conducted under DHA Facility License 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Test Overview & Methodology
This next-generation sequencing test analyses the entire FARS2 gene to diagnose Combined Oxidative Phosphorylation Deficiency Type 14 (COXPD14), a rare mitochondrial disorder that impairs cellular energy production. Our Illumina NovaSeq platform with LC-MS/MS confirmation delivers single-nucleotide and copy-number variant detection across the whole coding region and splice junctions.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Diagnostic Precision | Single-nucleotide & copy-number variants, full gene | Limited to known hotspots; may miss large deletions |
| Methodology | Illumina NovaSeq with LC-MS/MS confirmation | Capillary electrophoresis |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
NGS is the recommended first-tier method for comprehensive FARS2 analysis per international guidelines.
Physician Insight & Safety Protocols
“As a Consultant in Medical Genetics, I emphasise that a genetic result is a piece of a larger puzzle; the final diagnosis must be integrated with neurological, metabolic, and developmental evaluations. Never stop any prescribed medication based solely on this report—always consult your treating physician first.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria (Do NOT proceed with blood draw if):
- Acute febrile illness or active infection within the last 48 hours
- Haemodynamic instability requiring urgent medical attention
- Inability to provide informed consent (legal guardian required for minors under UAE Federal Decree-Law No. 4 of 2016 on Medical Liability)
Emergency Red Flags – Seek immediate medical care if you experience:
- Sudden worsening of muscle weakness, seizures, or loss of consciousness
- Severe metabolic acidosis symptoms (rapid breathing, confusion, vomiting)
- Any signs of anaphylaxis after sample collection (rare)
Patient FAQ & Clinical Guidance
1. Why is the FARS2 NGS test preferred over older mitochondrial panels?
FARS2 NGS delivers a 99.9% analytical sensitivity by sequencing the entire coding region and splice junctions, eliminating the false negatives common in targeted panels that overlook deep intronic mutations.
2. Can a blood spot on an FTA card give the same result as a whole blood draw?
Yes, a properly collected one-drop blood on an FTA card yields identical DNA quality for NGS, validated under our ISO 9001:2015 protocol with full concordance to venous blood.
3. How long before I receive the report and genetic counselling?
Turnaround is 3–4 weeks from sample accession; a certified genetic counsellor will call you to explain the results within 48 business hours of report release.
UAE Regulatory & Data Privacy Adherence
This test and all associated data handling comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent follows Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic information remains strictly confidential and is used solely for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | FARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 14 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA, 3–5 mL), Extracted DNA (≥1 µg, 260/280 1.8–2.0), or one-drop blood on FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina NovaSeq with LC-MS/MS confirmation |
| ICD-10-CM Code | E88.8 (Other specified metabolic disorders) |
| LOINC Code | 81247-9 (DNA sequencing panel) |
| DHA Facility License & Laboratory Address | DHA License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians